PharVision Advisers’s Ford F Stock Holding History

PharVision Advisers’s Portfolio F Stock Details F Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,996	Closed	-$150K	–	83
2026 Q1	$150K	Sell	12,996 -2,984	-19%	-$39.3K	1.52%	11
2025 Q4	$210K	Buy	15,980 +1,432	+10%	+$18.5K	0.11%	518
2025 Q3	$174K	Buy	+14,548	New	+$168K	0.1%	546

Other funds holding F

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PharVision Advisers's F Position: Q2 2026 in Review

PharVision Advisers sold out of Ford (F) in Q2 2026, closing a stake of 12,996 shares — an estimated $150K sold.

PharVision Advisers first reported a position in F in Q3 2025 and held it in 3 quarters. The position peaked at $210K in Q4 2025. 1,743 funds tracked by Wall St. Rank hold F as of Q2 2026.

PharVision Advisers reported no remaining Ford position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 12,996 Ford shares in Q2 2026, an estimated $150K.
PharVision Advisers first reported a position in Ford in Q3 2025 and held it in 3 quarters.
PharVision Advisers's Ford position peaked at $210K in Q4 2025.
1,743 funds tracked by Wall St. Rank held Ford as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.